Canada markets closed
  • S&P/TSX

    20,463.42
    +60.76 (+0.30%)
     
  • S&P 500

    4,443.11
    -12.37 (-0.28%)
     
  • DOW

    34,869.37
    +71.37 (+0.21%)
     
  • CAD/USD

    0.7920
    +0.0016 (+0.20%)
     
  • CRUDE OIL

    75.42
    +1.44 (+1.95%)
     
  • BTC-CAD

    54,248.86
    -982.08 (-1.78%)
     
  • CMC Crypto 200

    1,062.43
    -39.09 (-3.55%)
     
  • GOLD FUTURES

    1,749.80
    -1.90 (-0.11%)
     
  • RUSSELL 2000

    2,281.00
    +32.93 (+1.46%)
     
  • 10-Yr Bond

    1.4840
    +0.0240 (+1.64%)
     
  • NASDAQ futures

    15,171.50
    -147.25 (-0.96%)
     
  • VOLATILITY

    18.76
    +1.01 (+5.69%)
     
  • FTSE

    7,063.40
    +11.92 (+0.17%)
     
  • NIKKEI 225

    30,240.06
    -8.75 (-0.03%)
     
  • CAD/EUR

    0.6767
    +0.0027 (+0.40%)
     

Stocks in play: Levitee Labs Inc.

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Announced that it has executed the following definitive agreements. (1) Asset purchase agreement to acquire all material operating assets of ACT Medical Centres, Inc., comprised of a group of five addiction and pain management clinics across Alberta, for $350,000 in cash. A leader in addiction and substance abuse treatments, ACT Medical hosted more than 35,000 patient visits in the past 12 months. (2) Share purchase agreement to acquire all of the issued and outstanding shares of three pharmacies in Alberta specialized in filling prescriptions for patients with substance abuse disorders, mental health conditions and chronic pain. The purchase price under this agreement is $3,685,262, payable in cash plus or minus customary working capital adjustments. (3) Share purchase agreement to acquire BlockMD LTD., which operates a leading telemedicine platform used by addiction patients to access doctors and order prescriptions in Alberta, for $1,475,000. Over the last 12 months, BlockMD conducted over 20,000 patient visits remotely through its platform. The BlockMD Purchase Price will be paid through the issuance of Levitee common shares, the number of Shares to be determined on the date of closing, subject to downside protection in the event the Shares trade below a predetermined price 4 months and 1 day post-closing of the transaction. Levitee Labs Inc. shares C.LVT are trading up 3 cents at $0.58.

Read: The Story Behind Short Sellers' Desperate Battle Against Recon Africa

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting